Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile
- PMID: 20169081
- PMCID: PMC2821929
- DOI: 10.1371/journal.pone.0009252
Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile
Abstract
In recent years it has become clear that the therapeutic properties of bone marrow-derived mesenchymal stromal cells (MSC) are related not only to their ability to differentiate into different lineages but also to their capacity to suppress the immune response. We here studied the influence of MSC on macrophage function. Using mouse thioglycolate-elicited peritoneal macrophages (M) stimulated with LPS, we found that MSC markedly suppressed the production of the inflammatory cytokines TNF-alpha, IL-6, IL-12p70 and interferon-gamma while increased the production of IL-10 and IL-12p40. Similar results were observed using supernatants from MSC suggesting that factor(s) constitutively released by MSC are involved. Supporting a role for PGE(2) we observed that acetylsalicylic acid impaired the ability of MSC to inhibit the production of inflammatory cytokines and to stimulate the production of IL-10 by LPS-stimulated M. Moreover, we found that MSC constitutively produce PGE2 at levels able to inhibit the production of TNF-alpha and IL-6 by activated M. MSC also inhibited the up-regulation of CD86 and MHC class II in LPS-stimulated M impairing their ability to activate antigen-specific T CD4+ cells. On the other hand, they stimulated the uptake of apoptotic thymocytes by M. Of note, MSC turned M into cells highly susceptible to infection with the parasite Trypanosoma cruzi increasing more than 5-fold the rate of M infection. Using a model of inflammation triggered by s.c. implantation of glass cylinders, we found that MSC stimulated the recruitment of macrophages which showed a low expression of CD86 and the MHC class II molecule Ia(b) and a high ability to produce IL-10 and IL-12p40, but not IL-12 p70. In summary, our results suggest that MSC switch M into a regulatory profile characterized by a low ability to produce inflammatory cytokines, a high ability to phagocyte apoptotic cells, and a marked increase in their susceptibility to infection by intracellular pathogens.
Conflict of interest statement
Figures








Similar articles
-
Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.Stem Cell Res Ther. 2018 Oct 25;9(1):286. doi: 10.1186/s13287-018-1039-2. Stem Cell Res Ther. 2018. PMID: 30359316 Free PMC article.
-
Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.Arch Pharm Res. 2008 Apr;31(4):503-10. doi: 10.1007/s12272-001-1185-6. Epub 2008 May 1. Arch Pharm Res. 2008. PMID: 18449509
-
[Experimental study on influence of bone marrow mesenchymal stem cells on activation and function of mouse peritoneal macrophages].Zhonghua Xue Ye Xue Za Zhi. 2008 Aug;29(8):540-3. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 19112918 Chinese.
-
Macrophages at the nexus of mesenchymal stromal cell potency: The emerging role of chemokine cooperativity.Stem Cells. 2021 Sep;39(9):1145-1154. doi: 10.1002/stem.3380. Epub 2021 Apr 6. Stem Cells. 2021. PMID: 33786935 Free PMC article. Review.
-
The origins of mesenchymal stromal cell heterogeneity.Stem Cell Rev Rep. 2011 Sep;7(3):560-8. doi: 10.1007/s12015-011-9229-7. Stem Cell Rev Rep. 2011. PMID: 21437576 Review.
Cited by
-
Stem cell conditioned culture media attenuated albumin-induced epithelial-mesenchymal transition in renal tubular cells.Cell Physiol Biochem. 2015;35(5):1719-28. doi: 10.1159/000373984. Epub 2015 Mar 19. Cell Physiol Biochem. 2015. PMID: 25832005 Free PMC article.
-
Identification of IL-1β and LPS as optimal activators of monolayer and alginate-encapsulated mesenchymal stromal cell immunomodulation using design of experiments and statistical methods.Biotechnol Prog. 2015 Jul-Aug;31(4):1058-70. doi: 10.1002/btpr.2103. Epub 2015 May 28. Biotechnol Prog. 2015. PMID: 25958832 Free PMC article.
-
Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches.Drug Deliv Transl Res. 2023 Jul;13(7):1983-2014. doi: 10.1007/s13346-023-01290-2. Epub 2023 Feb 10. Drug Deliv Transl Res. 2023. PMID: 36763330 Free PMC article. Review.
-
Polarization Behavior of Bone Macrophage as Well as Associated Osteoimmunity in Glucocorticoid-Induced Osteonecrosis of the Femoral Head.J Inflamm Res. 2023 Feb 28;16:879-894. doi: 10.2147/JIR.S401968. eCollection 2023. J Inflamm Res. 2023. PMID: 36891172 Free PMC article. Review.
-
Mesenchymal Stem Cell Therapy for Cutaneous Wounds.Adv Wound Care (New Rochelle). 2012 Aug;1(4):166-171. doi: 10.1089/wound.2011.0294. Adv Wound Care (New Rochelle). 2012. PMID: 24527299 Free PMC article. Review.
References
-
- Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–147. - PubMed
-
- Chamberlain G, Fox J, Ashton B, Middleton J. Mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25:2739–2749. - PubMed
-
- Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110:3499–3506. - PubMed
-
- Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726–736. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials